Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis bags rights to Galapagos/MorphoSys atopic dermatitis drug

pharmatimesJuly 20, 2018

Tag: Novartis , MorphoSys , IL-17C , atopic dermatitis

PharmaSources Customer Service